Annual D&A
$43.71M$89.00K+0.20%
Summary
- Current Value
- As of today, TXG annual D&A is $43.71M, up +0.20% on
- Historical Performance
- TXG annual D&A is up +54.70% over the past 3 years, and up +518.57% over the past 5 years
- All-Time High Comparison
- TXG annual D&A is currently at its all-time high
- 3-Year Low Comparison
- TXG annual D&A is +32.42% above its 3-year low of $33.01M reached on an earlier date
- Sector Comparison
- TXG annual D&A is higher than 83.87% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $43.71M | +0.2% | +54.7% | +518.6% | +915.3% | |
| Quarterly D&A | $12.25M | +14.0% | +51.0% | +151.2% | – | |
| TTM D&A | $42.28M | -5.7% | +32.7% | +157.0% | – | |
| Price | $19.29 | +21.9% | -48.9% | -87.9% | – | |
| Annual SG&A | $344.34M | +0.3% | +33.7% | +163.2% | +636.8% | |
| Annual Total Expenses | $805.34M | -2.1% | +48.2% | +192.9% | +800.2% | |
| Annual Operating Expenses | $609.04M | -0.8% | +29.8% | +184.7% | +671.9% | |
| Annual Revenue | $610.79M | -1.3% | +24.5% | +148.4% | +759.2% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $43.71M | at high | |
| 5Y | $43.71M | at high | |
| All | $43.71M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $33.01M | N/A | +32.4% |
| 5Y | $19.02M | N/A | +129.8% |
| All | $3.91M | +1019.3% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $43.71M | +0.2% | |
| $43.62M | +32.2% | |
| $33.01M | +16.8% | |
| $28.25M | +48.5% |
| Year | Value | Change |
|---|---|---|
| $19.02M | +169.2% | |
| $7.07M | +80.9% | |
| $3.91M | -9.3% | |
| $4.31M | - |
FAQ
What is the current annual D&A of TXG?
As of today, TXG annual D&A is $43.71M
What is 1-year change in TXG annual D&A?
TXG annual D&A is up +0.20% year-over-year
What is 3-year change in TXG annual D&A?
TXG annual D&A is up +54.70% over the past 3 years
How far is TXG annual D&A from its all-time high?
TXG annual D&A is currently at its all-time high
How does TXG annual D&A rank versus sector peers?
TXG annual D&A is higher than 83.87% of companies in Healthcare sector
When is TXG next annual earnings release?
The next annual earnings release for TXG is on
Quarterly D&A
$12.25M$2.60M+26.94%
Summary
- Current Value
- As of today, TXG quarterly D&A is $12.25M, up +26.94% on
- Historical Performance
- TXG quarterly D&A is up +13.96% year-over-year, and up +50.97% over the past 3 years
- All-Time High Comparison
- TXG quarterly D&A is currently at its all-time high
- 3-Year Low Comparison
- TXG quarterly D&A is +44.61% above its 3-year low of $8.47M reached on an earlier date
- Sector Comparison
- TXG quarterly D&A is higher than 82.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $12.25M | +26.9% | +14.0% | +51.0% | +151.2% | |
| Annual D&A | $43.71M | – | +0.2% | +54.7% | +518.6% | |
| TTM D&A | $42.28M | +3.7% | -5.7% | +32.7% | +157.0% | |
| Price | $19.29 | +59.8% | +21.9% | -48.9% | -87.9% | |
| Quarterly SG&A | $75.36M | +1.2% | -7.8% | +2.7% | +46.2% | |
| Quarterly Total Expenses | $176.47M | +27.5% | -5.8% | +2.0% | +28.2% | |
| Quarterly Operating Expenses | $133.13M | -3.3% | -9.4% | -1.0% | +63.0% | |
| Quarterly Revenue | $149.00M | -13.8% | -1.8% | +13.7% | +107.5% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $12.25M | at high | |
| 3Y | $12.25M | at high | |
| 5Y | $12.25M | at high | |
| All | $12.25M | at high |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $9.65M | +26.9% | |
| 3Y | $8.47M | N/A | +44.6% |
| 5Y | $5.42M | N/A | +126.2% |
| All | $1.04M | +1082.5% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of TXG?
As of today, TXG quarterly D&A is $12.25M
What is TXG quarterly D&A most recent change?
TXG quarterly D&A was up +26.94% on September 30, 2025
What is 1-year change in TXG quarterly D&A?
TXG quarterly D&A is up +13.96% year-over-year
How far is TXG quarterly D&A from its all-time high?
TXG quarterly D&A is currently at its all-time high
How does TXG quarterly D&A rank versus sector peers?
TXG quarterly D&A is higher than 82.78% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
TTM D&A
$42.28M$1.50M+3.68%
Summary
- Current Value
- As of today, TXG TTM D&A is $42.28M, up +3.68% on
- Historical Performance
- TXG TTM D&A is down -5.73% year-over-year, and up +32.71% over the past 3 years
- All-Time High Comparison
- TXG TTM D&A is currently -9.07% below its historical high of $46.50M set on
- 3-Year Low Comparison
- TXG TTM D&A is +28.10% above its 3-year low of $33.01M reached on an earlier date
- Sector Comparison
- TXG TTM D&A is higher than 82.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $42.28M | +3.7% | -5.7% | +32.7% | +157.0% | |
| Annual D&A | $43.71M | – | +0.2% | +54.7% | +518.6% | |
| Quarterly D&A | $12.25M | +26.9% | +14.0% | +51.0% | +151.2% | |
| Price | $19.29 | +59.8% | +21.9% | -48.9% | -87.9% | |
| TTM SG&A | -$5.93B | -1845.6% | -1861.4% | -2149.7% | -3303.3% | |
| TTM Revenue | $641.81M | -0.4% | +1.9% | +27.4% | +145.1% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $43.71M | N/A | -3.3% |
| 3Y | $46.50M | -9.1% | |
| 5Y | $46.50M | -9.1% | |
| All | $46.50M | -9.1% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $40.78M | +3.7% | |
| 3Y | $33.01M | N/A | +28.1% |
| 5Y | $19.02M | N/A | +122.3% |
| All | $1.04M | +3981.1% |
TTM D&A History
FAQ
What is the current TTM D&A of TXG?
As of today, TXG TTM D&A is $42.28M
What is TXG TTM D&A most recent change?
TXG TTM D&A was up +3.68% on September 30, 2025
What is 1-year change in TXG TTM D&A?
TXG TTM D&A is down -5.73% year-over-year
How far is TXG TTM D&A from its all-time high?
TXG TTM D&A is currently -9.07% below its historical high of $46.50M set on March 31, 2024
How does TXG TTM D&A rank versus sector peers?
TXG TTM D&A is higher than 82.30% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg